Parkinson's disease drug ropinirole safely sl

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current treatments focus on reducing symptoms and providing supportive care. Reporting June 1 in the journal Cell Stem Cell, researchers from Japan show in an early clinical trial that the Parkinson’s disease drug ropinirole is safe to use in ALS patients and delayed disease progression by 27.9 weeks on average.

Related Keywords

Japan ,Tokyo ,Japanese ,Lou Gehrig ,Satoru Morimoto ,Hideyuki Okano ,Glaxosmithkline ,Japan Society For The Promotion Of Science ,Japanese Ministry Of Health Labor ,Okasan Kato Foundation Research Grant ,Keio University School Of Medicine ,National Centre Of Neurology ,Method Of Research ,Yukihiko Miyata Memorial ,Japan Agency For Medical Research ,Uehara Memorial Foundation ,Keio University Hospital ,Japanese Ministry Of Education ,Cell Stem ,Keio University School ,Stem Cell ,Japan Agency ,Medical Research ,Japan Society ,Yukihiko Miyata Memorial Trust ,Yoshio Koide Grant ,Japanese Ministry ,Health Labor ,National Centre ,Cell Press ,